InMed Pharmaceuticals (INM) Finished Goods (2022 - 2025)
InMed Pharmaceuticals (INM) posted quarterly Finished Goods of $378636.0 for Q4 2025, down 43.92% year-over-year from $675164.0 in Q4 2024, and up 28.0% quarter-over-quarter from $295809.0 in Q3 2025.
InMed Pharmaceuticals (INM) Finished Goods (2022 - 2025) Analysis & Trends
InMed Pharmaceuticals' Finished Goods history runs 4 years deep, the most recent figure standing at $378636.0 for Q4 2025.
- In Q4 2025, Finished Goods fell 43.92% year-over-year to $378636.0; the TTM figure through Dec 2025 stood at $378636.0 (down 43.92% YoY), while the FY2025 annual figure was $676178.0, down 19.58% from the prior year.
- Finished Goods for Q4 2025 stood at $378636.0, up from $295809.0 in the prior quarter.
- The five-year high for Finished Goods was $927182.0 in Q3 2024, with the low at $231956.0 in Q1 2025.
- The 4-year median for Finished Goods is $582161.0 (2022), against an average of $596273.0.
- The sharpest annual moves came in 2023 and 2025: Finished Goods jumped 88.73% in 2023, then slumped 68.1% in 2025.
- InMed Pharmaceuticals' Finished Goods stood at $605956.0 in 2022, then slipped by 7.94% to $557859.0 in 2023, then advanced by 21.03% to $675164.0 in 2024, then plunged by 43.92% to $378636.0 in 2025.
- Business Quant data shows INM's Finished Goods at $378636.0 in Q4 2025, $295809.0 in Q3 2025, and $676178.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | InMed Pharmaceuticals | 6.48 Mn | 1.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 378,636.00 |
| Sep 30, 2025 | 295,809.00 |
| Jun 30, 2025 | 676,178.00 |
| Mar 31, 2025 | 231,956.00 |
| Dec 31, 2024 | 675,164.00 |
| Sep 30, 2024 | 927,182.00 |
| Jun 30, 2024 | 840,812.00 |
| Mar 31, 2024 | 558,366.00 |
| Dec 31, 2023 | 557,859.00 |
| Sep 30, 2023 | 838,705.00 |
| Jun 30, 2023 | 893,506.00 |
| Mar 31, 2023 | 394,267.00 |
| Dec 31, 2022 | 605,956.00 |
| Jun 30, 2022 | 473,426.00 |